The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
The porphyrias: advances in diagnosis and treatment
Open accessAbstract
The inborn errors of heme biosynthesis, the porphyrias, are 8 genetically distinct metabolic disorders that can be classified as “acute hepatic,” “hepatic cutaneous,” and “erythropoietic cutaneous” diseases. Recent advances in understanding their pathogenesis and molecular genetic heterogeneity have led to improved diagnosis and treatment. These advances include DNA-based diagnoses for all the porphyrias, new understanding of the pathogenesis of the acute hepatic porphyrias, identification of the iron overload-induced inhibitor of hepatic uroporphyrin decarboxylase activity that causes the most common porphyria, porphyria cutanea tarda, the identification of an X-linked form of erythropoietic protoporphyria due to gain-of-function mutations in erythroid-specific 5-aminolevulinate synthase (ALAS2), and new and experimental treatments for the erythropoietic prophyrias. Knowledge of these advances is relevant for hematologists because they administer the hematin infusions to treat the acute attacks in patients with the acute hepatic porphyrias, perform the chronic phlebotomies to reduce the iron overload and clear the dermatologic lesions in porphyria cutanea tarda, and diagnose and treat the erythropoietic porphyrias, including chronic erythrocyte transfusions, bone marrow or hematopoietic stem cell transplants, and experimental pharmacologic chaperone and stem cell gene therapies for congenital erythropoietic protoporphyria. These developments are reviewed to update hematologists on the latest advances in these diverse disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Human Gene Mutation Database: 2008 update
Stenson, P. D., Mort, M., Ball, E. V., Howells, K., Phillips, A. D., Thomas, N. S., & Cooper, D. N. (2009) · Genome Medicine · doi:10.1186/gm13 · Cited by 873
Puy, H., Gouya, L., & Deybach, J.-C. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61925-5 · Cited by 729
Emery and Rimoin's Principles and Practice of Medical Genetics
Woods, C. G. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.7.614-a · Cited by 712
Recommendations for the Diagnosis and Treatment of the Acute Porphyrias
Anderson, K. E., Bloomer, J. R., Bonkovsky, H. L., Kushner, J. P., Pierach, C. A., Pimstone, N. R., & Desnick, R. J. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-6-200503150-00010 · Cited by 628
Self-citationNutritional Regulation of Hepatic Heme Biosynthesis and Porphyria through PGC-1α
Handschin, C., Lin, J., Rhee, J., Peyer, A.-K., Chin, S., Wu, P.-H., Meyer, U. A., & Spiegelman, B. M. (2005) · Cell · doi:10.1016/j.cell.2005.06.040 · Cited by 383
Structure and function of enzymes in heme biosynthesis
Layer, G., Reichelt, J., Jahn, D., & Heinz, D. W. (2010) · Protein Science · doi:10.1002/pro.405 · Cited by 357
Whatley, S. D., Ducamp, S., Gouya, L., Grandchamp, B., Beaumont, C., Badminton, M. N., Elder, G. H., Holme, S. A., Anstey, A. V., Parker, M., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.08.003 · Cited by 293
Acute Porphyrias: Pathogenesis of Neurological Manifestations
Meyer, U., Schuurmans, M., & Lindberg, R. (1998) · Seminars in Liver Disease · doi:10.1055/s-2007-1007139 · Cited by 231
Liver transplantation as a cure for acute intermittent porphyria
Soonawalla, Z. F., Orug, T., Badminton, M. N., Elder, G. H., Rhodes, J. M., Bramhall, S. R., & Elias, E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15646-8 · Cited by 195
Gouya, L., Martin-Schmitt, C., Robreau, A.-M., Austerlitz, F., Da Silva, V., Brun, P., Simonin, S., Lyoumi, S., Grandchamp, B., Beaumont, C., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/498620 · Cited by 187
Cited by
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria
Balwani, M., Sardh, E., Ventura, P., Peiró, P. A., Rees, D. C., Stölzel, U., Bissell, D. M., Bonkovsky, H. L., Windyga, J., Anderson, K. E., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1913147 · Cited by 608
Self-citationHeme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes
Chiabrando, D., Vinchi, F., Fiorito, V., Mercurio, S., & Tolosano, E. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00061 · Cited by 450
A CRISPR/Cas9 Vector System for Tissue-Specific Gene Disruption in Zebrafish
Ablain, J., Durand, E. M., Yang, S., Zhou, Y., & Zon, L. I. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.01.032 · Cited by 368
Reyes, A., & Huber, W. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1165 · Cited by 290
Acute Porphyrias in the USA: Features of 108 Subjects from Porphyrias Consortium
Bonkovsky, H. L., Maddukuri, V. C., Yazici, C., Anderson, K. E., Bissell, D. M., Bloomer, J. R., Phillips, J. D., Naik, H., Peter, I., Baillargeon, G., et al. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.06.036 · Cited by 264
Self-citation
Metadata
- Authors
- Balwani, M., & Desnick, R. J.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2012-11-29
- Volume
- 120
- Issue
- 23
- Pages
- 4496-4504
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2143603770
- Cited by
- 259
- References
- 32
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The porphyrias: advances in diagnosis and treatment. https://app.cochat.ai/papers/10.1182/blood-2012-05-423186
- The paper
- Balwani, M., & Desnick, R. J. (2012). The porphyrias: advances in diagnosis and treatment. Blood. https://doi.org/10.1182/blood-2012-05-423186
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.